The new horizons for treatment of Late-Onset Pompe Disease (LOPD)
Revue Neurologique, 2023 - Elsevier
Late-onset Pompe disease (LOPD) is a genetic myopathy causing skeletal muscle
weakness and severe respiratory impairment, due to the deficiency of the lysosomal enzyme …
weakness and severe respiratory impairment, due to the deficiency of the lysosomal enzyme …
The new horizons for treatment of Late-Onset Pompe Disease (LOPD).
C Guémy, P Laforêt - Revue Neurologique, 2023 - europepmc.org
Late-onset Pompe disease (LOPD) is a genetic myopathy causing skeletal muscle
weakness and severe respiratory impairment, due to the deficiency of the lysosomal enzyme …
weakness and severe respiratory impairment, due to the deficiency of the lysosomal enzyme …
The new horizons for treatment of Late-Onset Pompe Disease (LOPD)
C Guémy, P Laforêt - Revue neurologique, 2023 - pubmed.ncbi.nlm.nih.gov
Late-onset Pompe disease (LOPD) is a genetic myopathy causing skeletal muscle
weakness and severe respiratory impairment, due to the deficiency of the lysosomal enzyme …
weakness and severe respiratory impairment, due to the deficiency of the lysosomal enzyme …